GSK plc (LON: GSK)
London
· Delayed Price · Currency is GBP · Price in GBX
1,320.00
-2.00 (-0.15%)
Dec 20, 2024, 6:50 PM BST
GSK plc Revenue
GSK plc had revenue of 8.01B GBP in the quarter ending September 30, 2024, a decrease of -1.66%. This brings the company's revenue in the last twelve months to 31.31B, up 5.59% year-over-year. In the year 2023, GSK plc had annual revenue of 30.33B with 3.42% growth.
Revenue (ttm)
31.31B
Revenue Growth
+5.59%
P/S Ratio
1.72
Revenue / Employee
445.95K
Employees
70,212
Market Cap
53.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 38.20B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.46B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 76.10M |
GSK plc News
- 1 day ago - GSK reports mixed results from Phase 3 ovarian cancer study - Seeking Alpha
- 1 day ago - GSK's cancer drugs meet progression-free survival goal in late-stage trial - Reuters
- 5 days ago - Pharmaceutical leaders convene in Paris to unveil vaccine strategies - EURACTIV.com
- 5 days ago - European Activist Investor Bluebell Capital to Shut Hedge Fund - BNN Bloomberg
- 5 days ago - ‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse - Fortune
- 9 days ago - Pharma stocks: Divi’s Lab (+0.82%), IPCA (+0.83%) rise; Biocon (-1.86%), Glaxo (-1.44%) decline - Business Upturn
- 10 days ago - GSK Is Doing The Right Things But Can't Catch A Break - Rating Downgrade - Seeking Alpha
- 11 days ago - Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis - GlobeNewsWire